ARCUTIS BIOTHERAPEUTICS, INC. (ARQT)

SEC filing

ARCUTIS BIOTHERAPEUTICS, INC.

ARQT · CIK 1787306

4 · Aug 19, 2026 · Director Welgus Howard G. sold 4,730 shares at $26.18/share ($123.8K); exercised options for 8,192 shares

Director Welgus Howard G. sold 4,730 shares at $26.18/share ($123.8K); exercised options for 8,192 shares

FORM 4

xslF345X06/wk-form4_1787173021.xmlSEC.gov

Graphics and non-inline formats (not embedded below).